LumaSon

Product NDC: 0270-7099
11-digit product format: 002707099
Labeler code: 0270
Product ID: 0270-7099_3ef95ad6-f22a-4baa-8f4a-1f6aaa4f7e21
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: SULFUR HEXAFLUORIDE
Dosage form: KIT
Labeler: BRACCO DIAGNOSTICS INC
Application: NDA203684
Marketing category: NDA
Marketing start: 2015-01-15
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N203684-001	LUMASON	SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS		RLD, RS	2014-10-15

Orange Book patents#

Current patent rows page 1 of 1 · 5 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N203684-001	10232061	2038-07-06		Drug product	2019-03-25
N203684-001	10335502	2038-07-06		Drug product	2019-07-16
N203684-001	11723869	2039-05-15	U-3666	Drug product	2023-08-16
N203684-001	11723869	2039-05-15	U-3667	Drug product	2023-08-16
N203684-001	11723869	2039-05-15	U-3668	Drug product	2023-08-16

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N203684-001	LUMASON	60.7MG/25MG	FOR SUSPENSION / INTRAVENOUS	RLD, RS	2014-10-15	`3a93d1ddd44b…`

Observed Orange Book patent history#

Patent history page 1 of 4 · 160 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-10-15 13:18:30	2026-09	N203684-001	10232061	2038-07-06		Drug product	2019-03-25	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N203684-001	10335502	2038-07-06		Drug product	2019-07-16	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N203684-001	11723869	2039-05-15	U-3666	Drug product	2023-08-16	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N203684-001	11723869	2039-05-15	U-3667	Drug product	2023-08-16	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	N203684-001	11723869	2039-05-15	U-3668	Drug product	2023-08-16	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	N203684-001	10232061	2038-07-06		Drug product	2019-03-25	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N203684-001	10335502	2038-07-06		Drug product	2019-07-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N203684-001	11723869	2039-05-15	U-3666	Drug product	2023-08-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N203684-001	11723869	2039-05-15	U-3667	Drug product	2023-08-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N203684-001	11723869	2039-05-15	U-3668	Drug product	2023-08-16	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N203684-001	10232061	2038-07-06		Drug product	2019-03-25	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N203684-001	10335502	2038-07-06		Drug product	2019-07-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N203684-001	11723869	2039-05-15	U-3666	Drug product	2023-08-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N203684-001	11723869	2039-05-15	U-3667	Drug product	2023-08-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N203684-001	11723869	2039-05-15	U-3668	Drug product	2023-08-16	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N203684-001	10232061	2038-07-06		Drug product	2019-03-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N203684-001	10335502	2038-07-06		Drug product	2019-07-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N203684-001	11723869	2039-05-15	U-3666	Drug product	2023-08-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N203684-001	11723869	2039-05-15	U-3667	Drug product	2023-08-16	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N203684-001	11723869	2039-05-15	U-3668	Drug product	2023-08-16	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203684-001	10232061	2038-07-06		Drug product	2019-03-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203684-001	10335502	2038-07-06		Drug product	2019-07-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203684-001	11723869	2039-05-15	U-3666	Drug product	2023-08-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203684-001	11723869	2039-05-15	U-3667	Drug product	2023-08-16	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N203684-001	11723869	2039-05-15	U-3668	Drug product	2023-08-16	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N203684-001	10232061	2038-07-06		Drug product	2019-03-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N203684-001	10335502	2038-07-06		Drug product	2019-07-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N203684-001	11723869	2039-05-15	U-3666	Drug product	2023-08-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N203684-001	11723869	2039-05-15	U-3667	Drug product	2023-08-16	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N203684-001	11723869	2039-05-15	U-3668	Drug product	2023-08-16	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203684-001	10232061	2038-07-06		Drug product	2019-03-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203684-001	10335502	2038-07-06		Drug product	2019-07-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203684-001	11723869	2039-05-15	U-3666	Drug product	2023-08-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203684-001	11723869	2039-05-15	U-3667	Drug product	2023-08-16	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N203684-001	11723869	2039-05-15	U-3668	Drug product	2023-08-16	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203684-001	10232061	2038-07-06		Drug product	2019-03-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203684-001	10335502	2038-07-06		Drug product	2019-07-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203684-001	11723869	2039-05-15	U-3666	Drug product	2023-08-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203684-001	11723869	2039-05-15	U-3667	Drug product	2023-08-16	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N203684-001	11723869	2039-05-15	U-3668	Drug product	2023-08-16	`b8a1b40f171c…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N203684-001	NPP	2022-11-13	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N203684-001	NPP	2022-11-13	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N203684-001	NPP	2022-11-13	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N203684-001	I-728	2019-03-31	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N203684-001	NCE	2019-10-10	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N203684-001	NPP	2022-11-13	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N203684-001	NPP	2022-11-13	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N203684-001	NPP	2022-11-13	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N203684-001	NPP	2022-11-13	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N203684-001	NPP	2022-11-13	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N203684-001	NPP	2022-11-13	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N203684-001	I-728	2019-03-31	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N203684-001	NCE	2019-10-10	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N203684-001	NPP	2022-11-13	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N203684-001	I-728	2019-03-31	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N203684-001	NCE	2019-10-10	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N203684-001	I-728	2019-03-31	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N203684-001	NCE	2019-10-10	`ea99ee380514…`
2023-01-26 05:58 UTC	2023-01	N203684-001	NPP	2022-11-13	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N203684-001	NPP	2022-11-13	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N203684-001	NPP	2022-11-13	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N203684-001	NPP	2022-11-13	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N203684-001	NPP	2022-11-13	`cb3db0bc1861…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: LumaSon
Listing expiration: 2027-12-31

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
f8f6af59-3ac0-4f91-bbb3-7b013673234d	Product name	1	20170428

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Indexing SPL table
NDC	Effective	Indexing SPL	Related label
0270-7099-16	2022-08-26	e4f33bdf-aec0-d8a0-e053-dadaa90a6e4e	These highlights do not include all the information needed to use LUMASON ® safely and effectively. See full prescribing information for LUMASON. LUMASON (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use Initial U.S. Approval: 2014
0270-7099-16	2022-08-26	e4f33bdf-aec0-d8a0-e053-dadaa90a6e4e	These highlights do not include all the information needed to use LUMASON ® safely and effectively. See full prescribing information for LUMASON. LUMASON (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use Initial U.S. Approval: 2014
0270-7099-73	2022-08-26	e4f33bdf-9d4d-d8a0-e053-dadaa90a6e4e	These highlights do not include all the information needed to use LUMASON ® safely and effectively. See full prescribing information for LUMASON. LUMASON (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use Initial U.S. Approval: 2014
0270-7099-73	2022-08-26	e4f33bdf-9d4d-d8a0-e053-dadaa90a6e4e	These highlights do not include all the information needed to use LUMASON ® safely and effectively. See full prescribing information for LUMASON. LUMASON (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use Initial U.S. Approval: 2014
0270-7099-16	2022-07-29	e4f33bdf-aec0-d8a0-e053-dadaa90a6e4e	These highlights do not include all the information needed to use LUMASON ® safely and effectively. See full prescribing information for LUMASON. LUMASON (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use Initial U.S. Approval: 2014
0270-7099-16	2022-07-29	e4f33bdf-aec0-d8a0-e053-dadaa90a6e4e	These highlights do not include all the information needed to use LUMASON ® safely and effectively. See full prescribing information for LUMASON. LUMASON (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use Initial U.S. Approval: 2014
0270-7099-73	2022-07-29	e4f33bdf-9d4d-d8a0-e053-dadaa90a6e4e	These highlights do not include all the information needed to use LUMASON ® safely and effectively. See full prescribing information for LUMASON. LUMASON (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use Initial U.S. Approval: 2014
0270-7099-73	2022-07-29	e4f33bdf-9d4d-d8a0-e053-dadaa90a6e4e	These highlights do not include all the information needed to use LUMASON ® safely and effectively. See full prescribing information for LUMASON. LUMASON (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use Initial U.S. Approval: 2014

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0270-7099-16	LumaSon	1 in 1 KIT	KIT	1	19
0270-7099-16	LumaSon	5 in 1 BOX	KIT	5	19
0270-7099-73	LumaSon	5 in 1 BOX	KIT	5	10
0270-7099-73	LumaSon	1 in 1 KIT	KIT	1	10

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0270-7099-16	EA - Each	0270-7099	44aa2562-72b7-4524-a338-06ba42fda7fd	1	2015-09-10
0270-7099-73	EA - Each	0270-7099	8d471263-7eb8-410f-8898-7ebf6b522792	1	2021-03-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL), SODIUM SALT	ACTIVE INGREDIENT	841B886EJ7	LUMASON (SULFUR HEXAFLUORIDE) KIT [BRACCO DIAGNOSTICS INC]	1
DISTEAROYLPHOSPHATIDYLCHOLINE, DL-	ACTIVE INGREDIENT	EAG959U971	LUMASON (SULFUR HEXAFLUORIDE) KIT [BRACCO DIAGNOSTICS INC]	1
SULFUR HEXAFLUORIDE	ACTIVE INGREDIENT	WS7LR3I1D6	LUMASON (SULFUR HEXAFLUORIDE) KIT [BRACCO DIAGNOSTICS INC]	1
1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL), SODIUM SALT	ACTIVE MOIETY	841B886EJ7	LUMASON (SULFUR HEXAFLUORIDE) KIT [BRACCO DIAGNOSTICS INC]	1
DISTEAROYLPHOSPHATIDYLCHOLINE, DL-	ACTIVE MOIETY	EAG959U971	LUMASON (SULFUR HEXAFLUORIDE) KIT [BRACCO DIAGNOSTICS INC]	1
SULFUR HEXAFLUORIDE	ACTIVE MOIETY	WS7LR3I1D6	LUMASON (SULFUR HEXAFLUORIDE) KIT [BRACCO DIAGNOSTICS INC]	1
PALMITIC ACID	INACTIVE INGREDIENT	2V16EO95H1	LUMASON (SULFUR HEXAFLUORIDE) KIT [BRACCO DIAGNOSTICS INC]	1
POLYETHYLENE GLYCOL 4000	INACTIVE INGREDIENT	4R4HFI6D95	LUMASON (SULFUR HEXAFLUORIDE) KIT [BRACCO DIAGNOSTICS INC]	1
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	LUMASON (SULFUR HEXAFLUORIDE) KIT [BRACCO DIAGNOSTICS INC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0270-7099	LUMASON (SULFUR HEXAFLUORIDE) KIT LUMASON (SULFUR HEXAFLUORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [BRACCO DIAGNOSTICS INC]	18	Current NDC, Legacy NDC, 2 package rows	20230817_7c679424-c3f7-ed02-892f-20ca0d775089.zip
0270-7099	LUMASON (SULFUR HEXAFLUORIDE) KIT LUMASON (SULFUR HEXAFLUORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [BRACCO DIAGNOSTICS INC]	9	Current NDC, Legacy NDC, 2 package rows	20231128_69822a55-226c-f133-e3b8-2b5826667c5b.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
WS7LR3I1D6	SULFUR HEXAFLUORIDE	2551-62-4	SULFUR HEXAFLUORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0270-7099-16	00270709916	5 KIT in 1 BOX (0270-7099-16) / 1 KIT in 1 KIT * 25 mg in 1 VIAL * 5 mL in 1 SYRINGE	5 kit	2015-01-15	0000-00-00	No	No	Current
0270-7099-73	00270709973	5 KIT in 1 BOX (0270-7099-73) / 1 KIT in 1 KIT * 25 mg in 1 VIAL * 5 mL in 1 SYRINGE	5 kit	2020-01-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
LumaSon	BRACCO DIAGNOSTICS INC \| Bracco Suisse SA \| Vetter Pharma-Fertigung GmbH & Co. KG \| Bracco Imaging SPA	2026-09-09	HUMAN PRESCRIPTION DRUG LABEL	20
LumaSon	BRACCO DIAGNOSTICS INC \| Bracco Suisse SA \| Bracco Imaging SPA	2026-09-09	HUMAN PRESCRIPTION DRUG LABEL	11